A PROGRESS REPORT ON THE TREATMENT OF 157 PATIENTS WITH ADVANCED CANCER USING LYMPHOKINE-ACTIVATED KILLER-CELLS AND INTERLEUKIN-2 OR HIGH-DOSE INTERLEUKIN-2 ALONE

被引：2787

作者：

ROSENBERG, SA ^{[1
]}

LOTZE, MT ^{[1
]}

MUUL, LM ^{[1
]}

CHANG, AE ^{[1
]}

AVIS, FP ^{[1
]}

LEITMAN, S ^{[1
]}

LINEHAN, WM ^{[1
]}

ROBERTSON, CN ^{[1
]}

LEE, RE ^{[1
]}

RUBIN, JT ^{[1
]}

SEIPP, CA ^{[1
]}

SIMPSON, CG ^{[1
]}

WHITE, DE ^{[1
]}

机构：

[1] NIH, CTR CLIN, BETHESDA, MD 20892 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1987年 / 316卷 / 15期

关键词：

D O I：

10.1056/NEJM198704093161501

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：889 / 897

页数：9

共 27 条

[1] PHASE-I EVALUATION OF RECOMBINANT INTERLEUKIN-2 IN PATIENTS WITH ADVANCED MALIGNANT DISEASE [J].

ATKINS, MB ;

GOULD, JA ;

ALLEGRETTA, M ;

LI, JJ ;

DEMPSEY, RA ;

RUDDERS, RA ;

PARKINSON, DR ;

REICHLIN, S ;

MIER, JW .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (09) :1380-1391

[2] LYMPHOKINE-ACTIVATED KILLER CELL PHENOMENON - LYSIS OF NATURAL KILLER-RESISTANT FRESH SOLID TUMOR-CELLS BY INTERLEUKIN 2-ACTIVATED AUTOLOGOUS HUMAN PERIPHERAL-BLOOD LYMPHOCYTES [J].

GRIMM, EA ;

MAZUMDER, A ;

ZHANG, HZ ;

ROSENBERG, SA .

JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (06) :1823-1841

[3]

LAFRENIERE R, 1985, J IMMUNOL, V135, P4273

[4]

LAFRENIERE R, 1985, CANCER RES, V45, P3735

[5]

LOTZE MT, 1981, CANCER RES, V41, P4420

[6]

LOTZE MT, 1980, J IMMUNOL, V125, P1487

[7]

LOTZE MT, 1985, J IMMUNOL, V134, P157

[8] HIGH-DOSE RECOMBINANT INTERLEUKIN-2 IN THE TREATMENT OF PATIENTS WITH DISSEMINATED CANCER - RESPONSES, TREATMENT-RELATED MORBIDITY, AND HISTOLOGIC-FINDINGS [J].

LOTZE, MT ;

CHANG, AE ;

SEIPP, CA ;

SIMPSON, C ;

VETTO, JT ;

ROSENBERG, SA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (22) :3117-3124

[9]

LOTZE MT, 1985, J IMMUNOL, V135, P2865

[10]

MAZUMDER A, 1984, CANCER-AM CANCER SOC, V53, P896, DOI 10.1002/1097-0142(19840215)53:4<896::AID-CNCR2820530414>3.0.CO

← 1 2 3 →